{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:59:59Z","timestamp":1785419999648,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety, Republic of Korea","doi-asserted-by":"publisher","award":["16172MFDS199"],"award-info":[{"award-number":["16172MFDS199"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety, Republic of Korea","doi-asserted-by":"publisher","award":["18172MFDS252"],"award-info":[{"award-number":["18172MFDS252"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea","award":["HI13C0826"],"award-info":[{"award-number":["HI13C0826"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.01.068","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T18:06:14Z","timestamp":1549908374000},"page":"1457-1466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay"],"prefix":"10.1016","volume":"37","author":[{"given":"Wonil","family":"Chae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Jeung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baik Lin","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.01.068_b0005","unstructured":"World Health Organization. Influenza (seasonal) fact sheet; 2018."},{"key":"10.1016\/j.vaccine.2019.01.068_b0010","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2002.1625","article-title":"Mechanism of neutralization of influenza virus infectivity by antibodies","volume":"302","author":"Knossow","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.01.068_b0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/clinids\/5.4.723","article-title":"Summary of clinical trials of inactivated influenza vaccine - 1978","volume":"5","author":"La Montagne","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.068_b0020","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hygiene"},{"key":"10.1016\/j.vaccine.2019.01.068_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-1135(93)90027-5","article-title":"Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines","volume":"37","author":"Williams","year":"1993","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.01.068_b0030","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1750-2659.2011.00250.x","article-title":"Confronting the next pandemic\u2013workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27\u201329, 2010","volume":"5","author":"Hardy","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2019.01.068_b0035","doi-asserted-by":"crossref","unstructured":"Wood JM, Weir JP. Standardisation of inactivated influenza vaccines-Learning from history. 2018;12:195\u2013201.","DOI":"10.1111\/irv.12543"},{"key":"10.1016\/j.vaccine.2019.01.068_b0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3389\/fimmu.2018.01093","article-title":"Chaperna-mediated assembly of ferritin-based middle east respiratory syndrome-coronavirus nanoparticles","volume":"9","author":"Kim","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.01.068_b0045","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1096\/fj.201700747RR","article-title":"Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation","volume":"32","author":"Yang","year":"2018","journal-title":"FASEB J: Off Publ Federation Am Soc Exp Biol"},{"key":"10.1016\/j.vaccine.2019.01.068_b0050","doi-asserted-by":"crossref","first-page":"W281","DOI":"10.1093\/nar\/gks469","article-title":"Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion","volume":"40","author":"Thomsen","year":"2012","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2019.01.068_b0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0968-0004(99)01540-6","article-title":"NPS@: network protein sequence analysis","volume":"25","author":"Combet","year":"2000","journal-title":"Trends Biochem Sci"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.01.068_b0060","first-page":"S162","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective","volume":"30","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.vaccine.2019.01.068_b0065","doi-asserted-by":"crossref","first-page":"W96","DOI":"10.1093\/nar\/gkh354","article-title":"ClusPro: a fully automated algorithm for protein-protein docking","volume":"32","author":"Comeau","year":"2004","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2019.01.068_b0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0022-2836(73)90011-9","article-title":"Environment and exposure to solvent of protein atoms. Lysozyme and insulin","volume":"79","author":"Shrake","year":"1973","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2019.01.068_b0075","doi-asserted-by":"crossref","unstructured":"Kim P, Jang YH, Kwon SB, Lee CM, Han G, Seong BL. Glycosylation of hemagglutinin and neuraminidase of influenza A virus as signature for ecological spillover and adaptation among influenza reservoirs. Viruses 2018;10.","DOI":"10.3390\/v10040183"},{"key":"10.1016\/j.vaccine.2019.01.068_b0080","unstructured":"National Research Council Committee on Methods of Producing Monoclonal A. The National Academies Collection: Reports funded by National Institutes of Health. Monoclonal Antibody Production. Washington (DC): National Academies Press (US) National Academy of Sciences; 1999."},{"key":"10.1016\/j.vaccine.2019.01.068_b0085","unstructured":"5.3 Statistical analysis of results of biological assays and tests. European pharmacopoeia 7th edition. Strasbourg: Council Of Europe: European Pharmacopoeia Commission; 2010. p. 551\u201379."},{"key":"10.1016\/j.vaccine.2019.01.068_b0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jbi.2014.11.003","article-title":"An overview of bioinformatics tools for epitope prediction: implications on vaccine development","volume":"53","author":"Soria-Guerra","year":"2015","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2019.01.068_b0095","doi-asserted-by":"crossref","first-page":"e2677","DOI":"10.1371\/journal.pone.0002677","article-title":"Protein solubility and folding enhancement by interaction with RNA","volume":"3","author":"Choi","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.01.068_b0100","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bit.21218","article-title":"The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures","volume":"96","author":"Vera","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2019.01.068_b0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.72.1.93","article-title":"Studies on the primary structure of the influenza virus hemagglutinin","volume":"72","author":"Skehel","year":"1975","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2019.01.068_b0110","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nsmb.1456","article-title":"Viral membrane fusion","volume":"15","author":"Harrison","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2019.01.068_b0115","doi-asserted-by":"crossref","first-page":"12861","DOI":"10.1128\/JVI.01606-12","article-title":"Insights into avian influenza virus pathogenicity: the hemagglutinin precursor HA0 of subtype H16 has an alpha-helix structure in its cleavage site with inefficient HA1\/HA2 cleavage","volume":"86","author":"Lu","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.01.068_b0120","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1093\/emboj\/cdf559","article-title":"Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin","volume":"21","author":"Leikina","year":"2002","journal-title":"The EMBO J"},{"key":"10.1016\/j.vaccine.2019.01.068_b0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/bmc.2810","article-title":"Refolding of urea-denatured alpha-chymotrypsin by protein-folding liquid chromatography","volume":"27","author":"Congyu","year":"2013","journal-title":"Biomed Chromatogr: BMC"},{"key":"10.1016\/j.vaccine.2019.01.068_b0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1750-2659.2012.00375.x","article-title":"Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion","volume":"7","author":"Bodle","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2019.01.068_b0135","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/irv.12272","article-title":"A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines","volume":"8","author":"Schmeisser","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2019.01.068_b0140","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.vaccine.2015.01.034","article-title":"Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines","volume":"33","author":"Gravel","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.068_b0145","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1016\/j.vaccine.2008.09.015","article-title":"Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins","volume":"26","author":"Chun","year":"2008","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.01.068_b0150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4161\/hv.27115","article-title":"Quadrivalent influenza vaccine in the United States","volume":"10","author":"Suryadevara","year":"2014","journal-title":"Human Vacc Immunotherap"},{"key":"10.1016\/j.vaccine.2019.01.068_b0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/471157a","article-title":"Vaccinate for the next H2N2 pandemic now","volume":"471","author":"Nabel","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.01.068_b0160","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1128\/JVI.00511-10","article-title":"Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.01.068_b0165","doi-asserted-by":"crossref","first-page":"20949","DOI":"10.1073\/pnas.0710286104","article-title":"Identification of H2N3 influenza A viruses from swine in the United States","volume":"104","author":"Ma","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.01.068_b0170","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/JVI.02526-13","article-title":"Risk assessment of H2N2 influenza viruses from the avian reservoir","volume":"88","author":"Jones","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.01.068_b0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1179\/2047773213Y.0000000103","article-title":"Global alert to avian influenza virus infection: from H5N1 to H7N9","volume":"107","author":"Poovorawan","year":"2013","journal-title":"Pathogens Global Health"},{"key":"10.1016\/j.vaccine.2019.01.068_b0180","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1016\/j.vaccine.2006.10.051","article-title":"An overview of the epidemiology of avian influenza","volume":"25","author":"Alexander","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.068_b0185","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3201\/eid1309.070111","article-title":"Detecting human-to-human transmission of avian influenza A (H5N1)","volume":"13","author":"Yang","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.068_b0190","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"Imai","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.01.068_b0195","doi-asserted-by":"crossref","unstructured":"Khanna M, Sharma S, Kumar B. Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development. 2014;2014:546274.","DOI":"10.1155\/2014\/546274"},{"key":"10.1016\/j.vaccine.2019.01.068_b0200","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0092-8674(93)90260-W","article-title":"A spring-loaded mechanism for the conformational change of influenza hemagglutinin","volume":"73","author":"Carr","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.01.068_b0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/viro.1998.9224","article-title":"Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs","volume":"247","author":"Gambaryan","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.01.068_b0210","unstructured":"WHO. Generic protocol for the calibration of seasonal and pandemic influenza antigen working reagents by WHO essential regulatory laboratories. Sixty-second report of the Expert Committee on Biological Standardization, Annex 5. WHO Technical Report Series 979; 2013."},{"key":"10.1016\/j.vaccine.2019.01.068_b0215","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.vaccine.2011.12.056","article-title":"Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry","volume":"30","author":"Williams","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.068_b0220","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3892\/mmr.2014.3049","article-title":"A hemagglutinin quantification method for development of an influenza pandemic vaccine using size exclusion high performance liquid chromatography","volume":"11","author":"Roh","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.vaccine.2019.01.068_b0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nprot.2009.200","article-title":"A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide","volume":"5","author":"Li","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2019.01.068_b0230","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","article-title":"FluBlok, a next generation influenza vaccine manufactured in insect cells","volume":"37","author":"Cox","year":"2009","journal-title":"Biologicals: J Int Assoc Biol Standard"},{"key":"10.1016\/j.vaccine.2019.01.068_b0235","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/irv.12383","article-title":"An overview of the regulation of influenza vaccines in the United States","volume":"10","author":"Weir","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2019.01.068_b0240","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.01.068_b0245","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.vaccine.2019.01.068_b0250","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.vaccine.2015.05.038","article-title":"Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses","volume":"33","author":"Wohlbold","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:31:25Z","timestamp":1759401085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19301537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19301537"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}